Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HPV (human papilloma virus) urine detection option for poorer countries:

This article was originally published in Clinica

Executive Summary

Testing urine for the cervical cancer marker human papilloma virus (HPV) could provide developing countries with an easier, cheaper alternative to taking cervical swabs, according Zimbabwean researchers. In a study of 43 women with cervical cancer, published in the Journal of Medical Virology (September), urine-based tests identified HPV in 72% of cases, compared with 98% of samples from swabs. If the accuracy can be improved, urine samples could be used in cervical cancer screening programmes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel